placeholder image
M. S. Stockwell All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Effectiveness of RSV prevention strategies in US infants: 2024-2025. 
    Pediatrics. 2026
  • Influenza activity and estimated vaccine effectiveness during the 2025-2026 influenza season. 
    JAMA network open. 2026
  • Effectiveness of 2023-2024 COVID-19 vaccines in children in the United States. 
    Pediatrics. 2025
  • Effectiveness of 2024-2025 COVID-19 vaccines in children in the United States - VISION, August 29, 2024-September 2, 2025. 
    MMWR: Morbidity and Mortality Weekly Report. 2025
  • Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023-March 2024: a test-negative design analysis. 
    Lancet Reg Health Am. 2025
  • Clinical epidemiology and risk factors for critical outcomes among vaccinated and unvaccinated adults hospitalized with COVID-19-VISION Network, 10 states, June 2021-March 2023. 
    Clinical Infectious Diseases. 2024
  • Effectiveness of BNT162b2 COVID-19 vaccination in children and adolescents. 
    Pediatrics. 2023
  • Effectiveness of 2, 3, and 4 COVID-19 mRNA vaccine doses among immunocompetent adults during periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 sublineages predominated - VISION Network, 10 states, December 2021-June 2022. 
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19-associated emergency department and urgent care encounters and hospitalizations among nonimmunocompromised children and adolescents aged 5-17 years - VISION Network, 10 states, April 2021-January 2022. 
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Effectiveness of homologous and heterologous COVID-19 booster doses following 1 Ad.26.COV2.S (Janssen (Johnson & Johnson)) vaccine dose against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults - VISION Network, 10 states, December 2021-March 2022. 
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Estimation of COVID-19 mRNA vaccine effectiveness against medically attended COVID-19 in pregnancy during periods of Delta and Omicron variant predominance in the United States. 
    JAMA network open. 2022
  • Impacting delayed pediatric influenza vaccination: a randomized controlled trial of text message reminders. 
    American Journal of Preventive Medicine. 2015
  • Influenza vaccine text message reminders for urban, low-income pregnant women: a randomized controlled trial. 
    American Journal of Public Health. 2014
  • Effect of a text messaging intervention on influenza vaccination in an urban, low-income pediatric and adolescent population: a randomized controlled trial. 
    JAMA. 2012
  • Text4Health: impact of text message reminder-recalls for pediatric and adolescent immunizations. 
    American Journal of Public Health. 2012
  • Exploring pregnant women's views on influenza vaccination and educational text messages. 
    Preventive Medicine. 2011
  • Text message reminders to promote human papillomavirus vaccination. 
    Vaccine. 2011
  • The role of human papillomavirus vaccination in promoting delivery of other preventive and medical services. 
    Academic Pediatrics. 2011
  • Changes in Tdap and MCV4 vaccine coverage following enactment of a statewide requirement of Tdap vaccination for entry into sixth grade. 
    American Journal of Public Health. 2010
    • presentations
    Contact
    full name
  • M. S. Stockwell
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration